US 8431594
Bridged bicyclic heteroaryl substituted triazoles useful as AXL inhibitors
granted A61KA61K31/502A61P
Quick answer
US patent 8431594 (Bridged bicyclic heteroaryl substituted triazoles useful as AXL inhibitors) held by Rigel Pharmaceuticals, Inc. expires Mon Apr 25 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Rigel Pharmaceuticals, Inc.
- Grant date
- Tue Apr 30 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 25 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 3
- CPC classes
- A61K, A61K31/502, A61P, A61P13/12, A61P15/00